1-3 of 3
Thomas Neuhaus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Comparison of Intermediate-Dose Cytarabine Plus Mitoxantrone (IMA) Versus Standard-Dose Cytarabine Plus Daunorubicin (DA) for Induction Therapy in AML Patients >60 Years. Results from the SAL 60+ Trial

Christoph Röllig, MD, Michael Kramer, MSc., Maria Gabrecht, Mathias Hänel, Regina Herbst, MD, Ulrich Kaiser, Norbert Schmitz, MD PhD, Johannes Kullmer, Sebastian Fetscher, Hartmut Link, MDPhD, Luisa Mantovani-Löffler, Ulrich Krümpelmann, Thomas Neuhaus, Frank Heits, Hermann Einsele, Barbara Ritter, Martin Bornhäuser, MD, Johannes Schetelig, MD M. Sc,, Christian Thiede, MD, Brigitte Mohr, Markus Schaich, MD, Uwe Platzbecker, MD, Kerstin Schäfer-Eckart, Alwin Krämer, Wolfgang E Berdel, MD, Hubert Serve, MD, Gerhard Ehninger, MD, Ulrich S. Schuler, MD
Journal: Blood
Blood (2015) 126 (23): 222.
https://doi.org/10.1182/blood.V126.23.222.222
Published: 2015
Journal Articles

G-CSF Induced Expansion and Mobilization of Hematopoietic Stem Cells Is Altered by the Matrix Protein Osteopontin.

Randolf Forkert, MD, Yon Ko, MD, Thomas Neuhaus, MD, Elisabeth Gruenewald, Silke Schoeneborn, Hans Vetter, MD, Sebastian Stier, MD
Journal: Blood
Blood (2006) 108 (11): 1400.
https://doi.org/10.1182/blood.V108.11.1400.1400
Published: 2006
Journal Articles

Matrix Glycoprotein Osteopontin Is a Stem Cell Niche Constituent That Constrains the Hematopoietic Stem Cell Pool Size.

Sebastian Stier, MD, Yon Ko, MD, Randolf Forkert, MD, Christoph Lutz, MD, Thomas Neuhaus, MD, Elisabeth Gruenewald, David Dombkowski, Susan R. Rittling, David T. Scadden, MD
Journal: Blood
Blood (2004) 104 (11): 664.
https://doi.org/10.1182/blood.V104.11.664.664
Published: 2004